Omnipod 5, manufactured by Insulet, which is based in Acton, Massachusetts, is an AID system consisting of a wearable, tubeless insulin pump (the Pod), a Dexcom G6 CGM and the Omnipod 5 mobile application available on select smartphones or via a company-provided controller.28 Omnipod 5 was first granted FDA approval in January 2022 for people with T1D.29 The Pod’s built-i n SmartAdjust technology uses CGM values to increase, decrease or pause insulin delivery every 5 min based on customizable glucose target values (10 mg/dL intervals between 110 and 150 mg/dL). Here, INS is linked to type 1 diabetes mellitus.